http://repository.usmf.md:80/xmlui/handle/20.500.12710/12353 2026-04-09T21:53:40Z 2026-04-09T21:53:40Z http://repository.usmf.md:80/xmlui/handle/20.500.12710/16266 2021-09-23T11:46:07Z 2018-01-01T00:00:00Z

The Moldovan Medical Journal. June 2018, Vol. 61, No 2 The Moldovan Medical Journal is an international scientific double-blind peer-reviewed periodical edition, 6 per year, of the Scientific Medical Association of the Republic of Moldova designed for specialists in the areas of medicine, dentistry, pharmacy, social medicine, and public health. From its debut, the journal has striven to support the interests of Moldovan medicine concerning the new concepts of its development. The Editorial Board warmly welcomes both the readers of and the authors of the journal, all those who are enthusiastic about searching for new and more effective ways of solving numerous medical problems. We hope that those who want to make their contribution to the science of medicine will find our journal helpful and encouraging. Fondatori: Ministerul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie “Nicolae Testemiţanu”

2018-01-01T00:00:00Z Ceban, Emil http://repository.usmf.md:80/xmlui/handle/20.500.12710/14166 2021-09-23T11:46:19Z 2018-01-01T00:00:00Z

The monograph “The epidemiology of erectile dysfunction in the Republic of Moldova”, the author Ion Dumbraveanu Ceban, Emil Department of Urology and Surgical Nephrology, Nicolae Testemitsanu State University of Medicine and Pharmacy Chisinau, the Republic of Moldova

2018-01-01T00:00:00Z Martynchuk, Аlexandr Popovich, Sergei http://repository.usmf.md:80/xmlui/handle/20.500.12710/1185 2021-09-23T11:48:47Z 2018-01-01T00:00:00Z

Osteoarthrosis: possibilities of complex use of the medication Zeel T within the framework of bioregulatory approach Martynchuk, Аlexandr; Popovich, Sergei Background: In the article it is considered the essence and possibilities of the bioregulatory approach in the therapy of osteoarthrosis/osteoarthritis (OA) that is realized with the help of the use of complex bioregulatory medications (CBM) of the German company Biologische Heilmittel Heel GmbH. It is described in detail the composition and characteristics of the CBM Zeel T – the chondroprotective compound with a bioregulatory action. Zeel T is registered in the Republic of Moldova as a solution for injections, sublingual tablets and cream. Zeel T contributes to the restoration of the disturbed metabolic and reparative processes in the articular cartilage. There are considered important distinguishable moments of the mechanism of Zeel T action from the traditional chondroprotective compounds and its advantages. It should be noted that Zeel T has more than 40 years research history and it is widely used in more than 30 countries. Every year almost one million patients worldwide are treated with Zeel T. In the article it is presented the overview of clinical studies on the use of Zeel T at OA that demonstrate that Zeel T has comparable clinical efficacy with various traditional medicinal products (MP). Conclusions: It has also a good tolerability, does not cause characteristic for NSAIDs and corticosteroids (CS) side effects, and therefore can be used for a long time. The medicine is well combined with other medicinal products that increases the effectiveness and reduces the duration of the treatment course of OA. Department of Trauma, Hospital No 1 of Kiev, Department of Training, Ukrainian Academy of Biological Medicine, Kiev, Ukraine

2018-01-01T00:00:00Z Sciuca, Svetlana Antonovici, Natalia Dolganiuc, Angela http://repository.usmf.md:80/xmlui/handle/20.500.12710/1184 2021-09-23T11:49:00Z 2018-01-01T00:00:00Z

Modern approach to pediatric asthma Sciuca, Svetlana; Antonovici, Natalia; Dolganiuc, Angela Background: The article reviews aims to promote the communication between scientists engaged in basic research and clinicians working with children, in order to better understand the mechanism and work together towards an optimal management of this prominent pediatric condition. We reviewed the recent advancements in regards to pediatric asthma related to pathogenesis, diagnostic criteria and differential diagnosis, and peer-reviewed evidence for efficiency of pharmacological and non- pharmacological/alternative/adjuvant treatment; we also emphasize the importance of education of all parties involved in care, outpatient management, age-appropriate involvement of children in their own care, and asthma prevention measures in children. Clinically asthma is characterized by recurrent episodes of wheezing, dyspnea, and cough; at the pathophysiological level the airway wall thickness is increased and involves both smooth muscle and collagen tissue, the mucous glands and mucus production are increased, and the vascularity of the airways is increased, all leading to chronic inflammatory remodeling of the airways and resulting in reduction of lung function. Conclusions: Asthma among children has been on the rise for decades. With an estimated prevalence of 10-30%, asthma is the most prevalent chronic disease of pediatric population worldwide and one with a large health care burden. The approach to diagnosis and treatment of asthma in children is distinct from adults; so is the management, prevention and the education of parties involved in care. Recently there has been a significant progress in mechanistic understanding of asthma; further, asthma management in children is becoming a top priority Department of Pediatrics, Nicolae Testemitsanu State University of Medicine and Pharmacy, Chisinau, the Republic of Moldova, Department of General Pediatrics, Balti Children Hospital, Balti, the Republic of Moldova, Department of Pediatrics, Tozeur Regional Hospital, the Republic of Tunisia, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA

2018-01-01T00:00:00Z